Sofinnova BioEquities is a Hedge Fund in California, that has raised $357.89 mm from 65 investors, for an equity fund started in Jan 2017. Data from SEC filing on 9 May 2023.
Company profile
Employees
Incorporated
Location
Fiscal year end
Industry
SEC CIK
Address
Sofinnova BioEquities
3000 SAND HILL ROAD
BUILDING 4, SUITE 250
MENLO PARK
CA 94025
3000 SAND HILL ROAD
BUILDING 4, SUITE 250
MENLO PARK
CA 94025
Phone
650-681-8482
Ownership
Fund structure | AUM | Fund type |
---|---|---|
Sofinnova Investments, Inc. | $3.90 bn | |
Sofinnova Bioequities Master Fund, LTD. | $788.38 mm | Hedge Fund |
Sofinnova Bioequities Offshore Fund LTD. | ||
Sofinnova Bioequities, LP | ||
Sofinnova Synergy Master Fund, LP | $2.95 mm | Hedge Fund |
Sofinnova Venture Partners IX, L.P. | $476.56 mm | Venture Capital Fund |
Sofinnova Venture Partners VIII, L.P. | $175.21 mm | Venture Capital Fund |
Sofinnova Venture Partners X, L.P. | $888.87 mm | Venture Capital Fund |
Sofinnova Venture Partners XI, L.P. | $408.62 mm | Venture Capital Fund |
Latest filings (excl ownership)
D/A
Indefinite amount in investment fund / equity, sold $357.89 mm, 65 investors
9 May 23
D/A
Indefinite amount in investment fund / equity, sold $330.91M, 59 investors
9 May 22
D/A
Indefinite amount in investment fund / equity, sold $333.11M, 55 investors
14 May 21
D/A
Indefinite amount in investment fund / equity, sold $148.25M, 46 investors
15 May 20
D/A
Indefinite amount in investment fund / equity, sold $82.5M, 38 investors
15 May 19
D/A
Indefinite amount in investment fund / equity, sold $23.75M, 32 investors
15 May 18
D
Indefinite amount in investment fund / equity, sold $10.35M, 18 investors
15 May 17
Latest ownership filings
No filings